BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34682270)

  • 1. Selection of
    Hoffmann CV; Nevez G; Moal MC; Quinio D; Le Nan N; Papon N; Bouchara JP; Le Meur Y; Le Gal S
    J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting cluster of nosocomial pneumonia with a single Pneumocystis jirovecii genotype involving different organ allograft recipients.
    Hosseini-Moghaddam SM; Dufresne PJ; Hunter Gutierrez E; Dufresne SF; House AA; Humar A; Kumar D; Jevnikar AM
    Clin Transplant; 2020 Dec; 34(12):e14108. PubMed ID: 33048378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
    Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.
    Glander P; Waiser J; Hambach P; Bachmann F; Budde K; Eckardt KU; Friedersdorff F; Gaedeke J; Kron S; Lorkowski C; Mai M; Neumayer HH; Peters R; Rudolph B; Schmidt D; Wu K; Liefeldt L
    Transplantation; 2021 Apr; 105(4):916-927. PubMed ID: 32496356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
    Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
    Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural determinant of mycophenolic acid resistance in eukaryotic inosine 5'-monophosphate dehydrogenases.
    Freedman R; Yu R; Sarkis AW; Hedstrom L
    Protein Sci; 2020 Mar; 29(3):686-694. PubMed ID: 31675145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
    Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
    Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.
    Reine PA; Vethe NT; Kongsgaard UE; Andersen AM; Line PD; Ali AM; Bergan S
    Scand J Clin Lab Invest; 2013 Mar; 73(2):117-24. PubMed ID: 23281843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.
    Gensburger O; Van Schaik RH; Picard N; Le Meur Y; Rousseau A; Woillard JB; Van Gelder T; Marquet P
    Pharmacogenet Genomics; 2010 Sep; 20(9):537-43. PubMed ID: 20679962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.
    Fukuda T; Goebel J; Thøgersen H; Maseck D; Cox S; Logan B; Sherbotie J; Seikaly M; Vinks AA
    J Clin Pharmacol; 2011 Mar; 51(3):309-20. PubMed ID: 20418509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
    Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
    Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of
    Cheng YD; Huang CH; Gau SY; Chung NJ; Huang SW; Huang CY; Lee CY
    J Fungi (Basel); 2022 Dec; 9(1):. PubMed ID: 36675844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of IMP dehydrogenase with a role in self-resistance of mycophenolic acid producing fungi.
    Hansen BG; Genee HJ; Kaas CS; Nielsen JB; Regueira TB; Mortensen UH; Frisvad JC; Patil KR
    BMC Microbiol; 2011 Sep; 11():202. PubMed ID: 21923907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
    Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
    Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature.
    Bonnet PL; Hoffmann CV; Le Nan N; Bellamy L; Hoarau G; Flori P; Demar M; Argy N; Morio F; Le Gal S; Nevez G
    Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37656874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.
    Li H; Mager DE; Sandmaier BM; Storer BE; Boeckh MJ; Bemer MJ; Phillips BR; Risler LJ; McCune JS
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1121-9. PubMed ID: 24727337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5'-monophosphate dehydrogenase.
    Farazi T; Leichman J; Harris T; Cahoon M; Hedstrom L
    J Biol Chem; 1997 Jan; 272(2):961-5. PubMed ID: 8995388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
    Dong M; Fukuda T; Cox S; de Vries MT; Hooper DK; Goebel J; Vinks AA
    Br J Clin Pharmacol; 2014 Nov; 78(5):1102-12. PubMed ID: 24837828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.